Researcher

Professor Martin Gallagher


My Grants

      •  
  • Chief Investigator A, NHMRC MRFF Project Grant (#1170347) 2019: Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease (ACHIEVE) study. Value: $2,850,988.40
  • Chief Investigator A NHMRC Project Grant (#1148060) 2017: Kidney function and the effectiveness and safety of direct oral anticoagulants in atrial fibrillation: the KODIAK-AF study. Value: $445,493
  • Chief Investigator A NHMRC Project Grant...view more

My Grants

      •  
  • Chief Investigator A, NHMRC MRFF Project Grant (#1170347) 2019: Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease (ACHIEVE) study. Value: $2,850,988.40
  • Chief Investigator A NHMRC Project Grant (#1148060) 2017: Kidney function and the effectiveness and safety of direct oral anticoagulants in atrial fibrillation: the KODIAK-AF study. Value: $445,493
  • Chief Investigator A NHMRC Project Grant (#1127121) 2016: STARRT-AKI: Standard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury. Value: $2,112,446
  • Chief Investigator A NHMRC Partnership Grant (#1103241) 2015: Reducing the Burden of dialysis catheter complications: a national approach (REDUCCTION). Value: $1,192,236, with Partner Contribution of $1,877,010
  • Chief Investigator G NHMRC Project Grant (#1101765) 2015: Plasma-Lyte 148 versus Saline (PLUS) Trial. Value: $5,984,818
  • Chief Investigator D NHMRC Project Grant (#1098815) 2015: Establishing Core Outcomes in Haemodialysis. Value: $300,034
  • Chief Investigator E NHMRC Partnership Grant (#1055175) 2012: The Diabetes Renal Project: Better outcomes for patients with diabetes and chronic kidney disease. Value: $628,148
  • ANZ Society of Nephrology Infrastructure Grant, 2013. Value: $45,000
  • Kidney Health Australia Project Grant 2013. Value: $45,000
  • Kidney Health Australia Project Grant 2012. Value: $48,800
  • Chief Investigator B NHMRC Project Grant (#1030973) 2011: The SHARP-ER Study: Extended follow-up of the SHARP Study cohort. Value: $1,060,000.00
  • Jacquot Fellowship, RACP 2010 & 2011. Value: $90,000
  • Harkness Fellowship 2009-2010. Value: ~$110,000
  • Prestigious fellowship award to a single Australian health clinician or researcher to support 12 months research in USA awarded Dec 2008
      •  
  • Chief Investigator B NHMRC Project Grant (#1011387) 2010: Prevention of serious adverse events following angiography (PRESERVE) Study. Value: $2,323,394.40
  • Chief Investigator A NHMRC Project Grant (#632811) 2009: Extended follow up of the RENAL Study and individual patient data meta-analysis. Value: $625,000.
  • NHMRC Post-graduate Research Scholarship 2008-2009. Value: ~$28,000
  • NHMRC Renal CCRE Post-graduate Research Scholarship 2007. Value ~$28,000

My Qualifications

 

  • University of Adelaide, MB BS 1991
  • Royal Australasian College of Physicians, Fellow (FRACP) 1999
  • University of Sydney, MPH (Hons) 2003
  • University of Sydney, PhD 2010

My Awards

 

  • Senior author Kidney Health Ausrralia Best Clinical Research Award ANZSM 2021 (awarded to Dr Sradha Kotwal)
  • Co-author on Best Young Investigator Award (Clinical) ANZSN ASM Perth 2016 (awarded to Emma O’Lone)
  • Senior investigator on paper awarded Best Young Investigator Award (Clinical) ANZSN ASM Auckland 2012 (awarded to Dr Min Jun)
  • Finalist KHA Clinical Science Award, ANZSN ASM Auckland 2012
  • Co-author on Best Clinical Presentation at ANZ Society of Nephrology ASM (Awarded to Alan Cass), Hobart 2009
  • Best Poster in Clinical Science at ANZ Society of Nephrology ASM, Newcastle 2008
  • Kidney Health Australia Award for Best Clinical Presentation at Transplantation Society of ANZ Annual Scientific Meeting, 2007
  • Finalist in Kidney Health Australia Best Clinical Nephrology Presentation at ANZSN, Gold Coast 2007
  • Excellence in teaching award 2006 & 2007, Concord Clinical School, USYD
  • National Institute of Clinical Studies Cochrane Users Award 2003
  • National Award for application of Cochrane Database evidence into clinical practice for VTE Prevention in a large teaching hospital.
  • Glaxo-Smith-Kline Travel Award for Advanced Research in Organ Transplantation at Transplantation Society of ANZ Annual Scientific Meeting, Canberra, 2002
  • Young Investigator Award at Transplantation Society of ANZ Annual Scientific Meeting, Canberra, 2002
  • Nominated for President’s Prize at Transplantation Society of ANZ Annual Scientific Meeting, Canberra, 2002
  • Quality First Awards: ACT wide award for clinical practice improvement
  • Safety category 2002,
  • Effectiveness category 2003.
  • John Graham Prize for Services to RNSH RMOA 1992
View less